Brant Allen Inman
Professor of Surgery
Clinical research interests:
Clinical trials of novel diagnostic tests and therapies for genitourinary malignancies, with a strong focus on bladder cancer.
Basic science research interests:
Immune therapies for cancer, hyperthermia and heat-based treatment of cancer, molecular biology of genitourinary cancers, novel diagnostics and therapies for genitourinary cancers
Clinical trials of novel diagnostic tests and therapies for genitourinary malignancies, with a strong focus on bladder cancer.
Basic science research interests:
Immune therapies for cancer, hyperthermia and heat-based treatment of cancer, molecular biology of genitourinary cancers, novel diagnostics and therapies for genitourinary cancers
Current Appointments & Affiliations
- Professor of Surgery, Surgery, Urology, Surgery 2021
- Member of the Duke Cancer Institute, Duke Cancer Institute, Institutes and Centers 2008
Contact Information
- 3007 Snyderman Bldg, 905 La Salle Street, Durham, NC 27710
- DUMC Box 103868, Durham, NC 27710
-
(919) 681-1322
- Background
-
Education, Training, & Certifications
- M.S., Mayo Clinic, Alix School of Medicine 2011
- Fellowship, Urologic Oncology, Mayo Clinic 2005 - 2008
- Residency, Urology, Universite Laval (Canada) 2001 - 2005
- M.D., University of Alberta (Canada) 2000
- B.S., University of Alberta (Canada) 1999
-
Medical Licensure
- 148561. North Carolina. 2008
-
Previous Appointments & Affiliations
- Associate Professor of Surgery, Surgery, Urology, Surgery 2018 - 2021
- Associate Professor of Surgery, Surgery, Urology, Surgery 2014 - 2017
- Assistant Professor of Surgery, Surgery, Urology, Surgery 2013 - 2014
- Cary N. Robertson, MD, Assistant Professor, Surgery, Urology, Surgery 2013 - 2014
- Assistant Professor of Surgery, Surgery, Urology, Surgery 2008 - 2012
- Recognition
-
In the News
-
JUL 3, 2021 -
APR 1, 2021 -
FEB 23, 2021 -
JUL 19, 2020 -
APR 10, 2020 -
DEC 2, 2017 -
OCT 5, 2017 -
DEC 15, 2015 The Wall Street Journal -
FEB 16, 2015 -
MAR 12, 2014 -
MAR 2, 2011 -
JUN 18, 2009 -
AUG 1, 2007
-
-
Awards & Honors
- Leadership program. American Urological Association. 2017
- Reviewer of the month. European Urology. February 2016
- Platinum Scalpel Award for Excellence in Teaching. Division of Urology, Duke University. June 2015
- International exchange scholar. European Association of Urology and American Urological Association. March 2014
- Best Clinical Paper of 2014. International Journal of Hyperthermia. 2014
- Honorary Judge, Ferdinand C. Valentine Contest . New York Academy of Medicine. 2013
- Best reviewer, prostate cancer. Journal of Urology. 2008
- Best of posters, bladder cancer, basic science. American Urological Association. 2007
- Merit award. ASCO Foundation. 2007
- Merit award. ASCO Prostate Cancer Symposium . 2007
- Merit award. ASCO Prostate Cancer Symposium . 2006
- Clinical prize essay. Canadian Urologic Association . 2005
- Gerald P. Murphy Scholar . American Urological Association. 2004
- Clinical prize essay. Quebec Urologic Association . 2003
- Basic science prize essay. Quebec Urologic Association . 2002
- Clinical prize essay. Quebec Urologic Association . 2001
- Letter of exceptional proficiency, general surgery. University of Calgary. 2001
- Letter of exceptional proficiency, internal medicine. University of Calgary. 2001
- Dr. Morris Weinlos Prize in Pathology & Surgery . University of Alberta. 2000
- MRC Burroughs Wellcome Research Studentship . University of Alberta. 1996
- Student Bursary. College of Physicians and Surgeons of Alberta . 1996
- Research Studentship. Alberta Heritage Foundation for Medical Research . 1995
- Louise McKinney Post-Secondary Scholarship . Government of Alberta (Canada). 1994
- Alexander Rutherford Post-Secondary Scholarship . Government of Alberta (Canada). 1993
- Bronze medal for academic achievement. Governor General of Canada. 1993
- Expertise
-
Subject Headings
- BCG Vaccine
- Cancer Vaccines
- Carcinoma, Renal Cell
- Clinical Trial
- Cystectomy
- Immunotherapy
- Immunotherapy, Adoptive
- Kidney Neoplasms
- Magnetic nanoparticle hyperthermia
- Metastasectomy
- Nephrectomy
- Penile Neoplasms
- Prostate
- Prostatic Neoplasms
- Testicular Diseases
- Testicular Neoplasms
- Thermotherapy
- Urethral Neoplasms
- Urinary Bladder Neoplasms
- Urinary Diversion
- Urologic Neoplasms
- Urology
- Research
-
Selected Grants
- Enfortumab vedotin treatment in non-muscle invasive bladder cancer Pro00108709 awarded by Seagen, Inc 2021 - 2031
- A Phase 3 Study of CG0070 in Patients with Non-Muscular Invasive Bladder Cancer (NMIBC) Unresponsive to Bacillus CalmetteGuerin (BCG) awarded by CG Oncology, Inc. 2021 - 2031
- A Phase 3, Multi-center, Randomized Study Evaluating Efficacy of TAR-200 in Combination With Cetrelimab Versus Concurrent Chemoradiotherapy in Participants With Muscle-Invasive Urothelial Carcinoma (M awarded by Janssen Research & Development, LLC 2021 - 2028
- LUMINOS-103: A Basket Trial Evaluating the Safety and Efficacy of PVSRIPO and PVSRIPO in Combination with Anti-PD-1/L1 Checkpoint Inhibitors in Patients with Advanced Solid Tumors awarded by Istari Oncology 2021 - 2026
- PHASE III, OPEN-LABEL, MULTICENTER, RANDOMIZED STUDY BLADDER CANCER awarded by Genentech, Inc. 2015 - 2024
- Phase 3, Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial of Infigratinib for the Adjuvant Treatment of Subjects with Invasive Urothelial Carcinoma with Susceptible FGFR3 Genetic Altera awarded by QED Therapeutics 2020 - 2023
- Duke CTSA (TL1) Year 5 awarded by National Institutes of Health 2018 - 2023
- Plasmonic nanoparticle-mediated immunotherapy to treat metastatic cancer awarded by National Institutes of Health 2022 - 2023
- Genomic Subtyping and Profiling T1/T2 UC of Bladder - Pro00106608 awarded by Decipher Biosciences, Inc. 2021 - 2023
- PSA level during midlife and undiagnosed prostate cancer at autopsy: Understanding tumor biology and racial disparities awarded by Massachusetts General Hospital 2022
- Translational Research in Surgical Oncology awarded by National Institutes of Health 2002 - 2022
- A Phase III, Open Label Study to Evaluate the Safety and Efficacy of INSTILADRIN® (rAd-IFN/Syn3) Administered Intravesically to Patients with High Grade, BCG Unresponsive Non-Muscle Invasive Bladder C awarded by FKD Therapies Oy 2017 - 2022
- A PHASE Ib/II, OPEN-LABEL STUDY OF THE SAFETY AND PHARMACOLOGY OF ATEZOLIZUMAB ADMINISTERED WITH OR WITHOUT BACILLE CALMETTE-GUÉRIN IN PATIENTS WITH HIGH-RISK NON¿MUSCLEINVASIVE BLADDER CANCER awarded by Genentech, Inc. 2016 - 2021
- A Canine Model for Human High-Risk Non-Muscle Invasive Human Bladder Cancer-Molecular and Environmental Considerations awarded by North Carolina State University 2019 - 2021
- The Efficacy of the Bladder EpiCheck for Detection of Recurrent Urothelial Cell Carcinoma A Multicenter, Prospective Blinded Pivotal Study awarded by Nucleix Ltd. 2017 - 2021
- Heat Targeted Therapy for Bladder Cancer awarded by Urology Care Foundation 2019 - 2020
- TAR-200 Study awarded by TARIS Biomedical, LLC 2018 - 2020
- Synergistic Immuno-Photo-Nanotherapy for Bladder Cancer awarded by Department of Defense 2017 - 2020
- Therapeutic targeting of B7-H3 to reverse prostate cancer treatment resistance. awarded by Department of Defense 2016 - 2020
- BMS Bladder and Prostate Practicum 2019 awarded by Bristol-Myers Squibb Company 2019
- Evaluation of the UroVysion Test in Predicting Recurrence and/or Progression of Disease in Patients Receiving initial BCG for Primary High Grade Ta-T1 and CIS Urothelial Carcinoma of the Bladder awarded by Abbott Molecular Diagnostics 2013 - 2019
- A Phase 3 Multicenter Trial Evaluating the Efficacy and Safety of MitoGel on Ablation of Upper Urinary Tract Urothelial Carcinoma awarded by UroGen Pharma Ltd 2017 - 2019
- Pig Bladder Hyperthermia Testing Device awarded by Combat Medical 2017 - 2018
- Bladder Tumor TURBT Study awarded by GenomeDx Biosciences, Inc. 2017 - 2018
- Phase II Trial of Aerobic Training in Metastatic Breast Cancer awarded by National Institutes of Health 2010 - 2014
- Randomized Trial of Optimal Type of Aerobic Training in Breast Cancer awarded by National Institutes of Health 2010 - 2014
-
External Relationships
- Biom'Up SA
- CG Oncology
- Combat Medical
- Fergene
- Genentech, Inc (Roche Holding)
- Istari Oncology Inc.
- Janssen Oncology
- Johnson & Johnson
- QED Therapeutics
- Seattle Genetics
- Urogen
- Veracyte
- Publications & Artistic Works
-
Selected Publications
-
Academic Articles
-
Inman BA. Personalized Medicine in Genitourinary Oncology Is Happening Now. Eur Urol Focus. 2022 Jun 17;Full Text Link to Item
-
Rigiroli F, Zhang D, Molinger J, Wang Y, Chang A, Wischmeyer PE, et al. Automated versus manual analysis of body composition measures on computed tomography in patients with bladder cancer. Eur J Radiol. 2022 Jun 16;154:110413.Full Text Link to Item
-
Abern MR, Dudinec JV, Inman BA. Genomic Sequencing Should Not be Part of the Standard of Care for Most Urologic Cancers. Eur Urol Focus. 2022 May 7;Full Text Link to Item
-
Cheng Q, Butler W, Zhou Y, Zhang H, Tang L, Perkinson K, et al. Pre-existing Castration-resistant Prostate Cancer-like Cells in Primary Prostate Cancer Promote Resistance to Hormonal Therapy. Eur Urol. 2022 May;81(5):446–55.Full Text Open Access Copy Link to Item
-
Guerrero-Ramos F, González-Padilla DA, González-Díaz A, de la Rosa-Kehrmann F, Rodríguez-Antolín A, Inman BA, et al. Recirculating hyperthermic intravesical chemotherapy with mitomycin C (HIVEC) versus BCG in high-risk non-muscle-invasive bladder cancer: results of the HIVEC-HR randomized clinical trial. World J Urol. 2022 Apr;40(4):999–1004.Full Text Open Access Copy Link to Item
-
Mitra AP, Narayan VM, Mokkapati S, Miest T, Boorjian SA, Alemozaffar M, et al. Antiadenovirus Antibodies Predict Response Durability to Nadofaragene Firadenovec Therapy in BCG-unresponsive Non-muscle-invasive Bladder Cancer: Secondary Analysis of a Phase 3 Clinical Trial. Eur Urol. 2022 Mar;81(3):223–8.Full Text Open Access Copy Link to Item
-
Kibel AS, Inman BA, Pachynski RK, Vu T, Sheikh NA, Petrylak DP. Videos of Sipuleucel-T Programmed T Cells Lysing Cells That Express Prostate Cancer Target Antigens. J Natl Cancer Inst. 2022 Feb 7;114(2):310–3.Full Text Open Access Copy Link to Item
-
Berger M, Browndyke JN, Cooter Wright M, Nobuhara C, Reese M, Acker L, et al. Postoperative changes in cognition and cerebrospinal fluid neurodegenerative disease biomarkers. Ann Clin Transl Neurol. 2022 Feb;9(2):155–70.Full Text Link to Item
-
Browndyke JN, Wright MC, Yang R, Syed A, Park J, Hall A, et al. Perioperative neurocognitive and functional neuroimaging trajectories in older APOE4 carriers compared with non-carriers: secondary analysis of a prospective cohort study. Br J Anaesth. 2021 Dec;127(6):917–28.Full Text Open Access Copy Link to Item
-
Harrison MR, Costello BA, Bhavsar NA, Vaishampayan U, Pal SK, Zakharia Y, et al. Re: Active Surveillance of Metastatic Renal Cell Carcinoma: Results from a Prospective Observational Study (MaRCC). Journal of Urology. 2021 Dec;206(6):1515–6.Link to Item
-
Liu Y, Chorniak E, Odion R, Etienne W, Nair SK, Maccarini P, et al. Plasmonic gold nanostars for synergistic photoimmunotherapy to treat cancer. Nanophotonics. 2021 Sep 2;10(12):3295–302.Full Text Open Access Copy
-
Grimberg DC, Dudinec J, Shah A, Inman BA. Clinical trial of high dose hyperthermic intravesical mitomycin C for intermediate and high-risk non-muscle invasive bladder cancer during BCG shortage. Urol Oncol. 2021 Aug;39(8):498.e13-498.e20.Full Text Open Access Copy Link to Item
-
Harrison MR, Costello BA, Bhavsar NA, Vaishampayan U, Pal SK, Zakharia Y, et al. Active surveillance of metastatic renal cell carcinoma: Results from a prospective observational study (MaRCC). Cancer. 2021 Jul 1;127(13):2204–12.Full Text Open Access Copy Link to Item
-
Wang Y, Chang A, Tan WP, Fantony JJ, Gopalakrishna A, Barton GJ, et al. Diet and Exercise Are not Associated with Skeletal Muscle Mass and Sarcopenia in Patients with Bladder Cancer. Eur Urol Oncol. 2021 Apr;4(2):237–45.Full Text Open Access Copy Link to Item
-
Terrando N, Park JJ, Devinney M, Chan C, Cooter M, Avasarala P, et al. Immunomodulatory lipid mediator profiling of cerebrospinal fluid following surgery in older adults. Sci Rep. 2021 Feb 4;11(1):3047.Full Text Open Access Copy Link to Item
-
Campbell SP, Inman BA. Editorial Comment. J Urol. 2021 Feb;205(2):390–1.Full Text Open Access Copy Link to Item
-
Boorjian SA, Alemozaffar M, Konety BR, Shore ND, Gomella LG, Kamat AM, et al. Intravesical nadofaragene firadenovec gene therapy for BCG-unresponsive non-muscle-invasive bladder cancer: a single-arm, open-label, repeat-dose clinical trial. Lancet Oncol. 2021 Jan;22(1):107–17.Full Text Open Access Copy Link to Item
-
VanDusen KW, Li Y-J, Cai V, Hall A, Hiles S, Thompson JW, et al. Cerebrospinal Fluid Proteome Changes in Older Non-Cardiac Surgical Patients with Postoperative Cognitive Dysfunction. J Alzheimers Dis. 2021;80(3):1281–97.Full Text Open Access Copy Link to Item
-
Barton GJ, Tan WP, Inman BA. The nephroureterectomy: a review of technique and current controversies. Transl Androl Urol. 2020 Dec;9(6):3168–90.Full Text Open Access Copy Link to Item
-
Grimberg DC, Shah A, Inman BA. En Bloc Resection of Bladder Tumors: Style or Substance? Eur Urol. 2020 Oct;78(4):570–1.Full Text Open Access Copy Link to Item
-
Shah A, Tan WP, Inman BA. National Quality Improvement Program in Transurethral Resection of Bladder Tumor: A Model for the Rest of Us, Even if We Cannot Share All Results. Eur Urol. 2020 Oct;78(4):531–2.Full Text Open Access Copy Link to Item
-
Grimberg DC, Shah A, Molinger J, Whittle J, Gupta RT, Wischmeyer PE, et al. Assessments of frailty in bladder cancer. Urol Oncol. 2020 Sep;38(9):698–705.Full Text Open Access Copy Link to Item
-
Shah A, Grimberg DC, Inman BA. From Dog's Breakfast to Michelin Guide: Post-bacillus Calmette-Guérin Trials in Non-muscle-invasive Bladder Cancer. Eur Urol. 2020 Sep;78(3):400–1.Full Text Open Access Copy Link to Item
-
Sloan FA, Yashkin AP, Akushevich I, Inman BA. The Cost to Medicare of Bladder Cancer Care. Eur Urol Oncol. 2020 Aug;3(4):515–22.Full Text Open Access Copy Link to Item
-
Grimberg DC, Shah A, Inman BA. Overview of Taris GemRIS, a Novel Drug Delivery System for Bladder Cancer. Eur Urol Focus. 2020 Jul 15;6(4):620–2.Full Text Open Access Copy Link to Item
-
Akushevich I, Yashkin AP, Inman BA, Sloan F. Partitioning of time trends in prevalence and mortality of bladder cancer in the United States. Ann Epidemiol. 2020 Jul;47:25–9.Full Text Open Access Copy Link to Item
-
Nobuhara CK, Bullock WM, Bunning T, Colin B, Cooter M, Devinney MJ, et al. A protocol to reduce self-reported pain scores and adverse events following lumbar punctures in older adults. J Neurol. 2020 Jul;267(7):2002–6.Full Text Link to Item
-
Kamat AM, Lerner SP, O’Donnell M, Georgieva MV, Yang M, Inman BA, et al. Evidence-based Assessment of Current and Emerging Bladder-sparing Therapies for Non-muscle-invasive Bladder Cancer After Bacillus Calmette-Guerin Therapy: A Systematic Review and Meta-analysis. Eur Urol Oncol. 2020 Jun;3(3):318–40.Full Text Open Access Copy Link to Item
-
Moul JW, Chang A, Inman BA. Managing Prostate Cancer Surgical Patients during the COVID-19 Pandemic: A Brief Report of the Duke Cancer Institute's Initial Experience. Oncology (Williston Park). 2020 May 13;34(5):156–62.Open Access Copy Link to Item
-
Flaig TW, Spiess PE, Agarwal N, Bangs R, Boorjian SA, Buyyounouski MK, et al. Bladder Cancer, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2020 Mar;18(3):329–54.Full Text Link to Item
-
Lotan Y, Inman BA, Davis LG, Kassouf W, Messing E, Daneshmand S, et al. Reply by Authors. J Urol. 2020 Mar;203(3):625–6.Full Text Link to Item
-
Meleis L, Moore R, Inman BA, Harrison MR. Retrospective analysis of the efficacy and safety of neoadjuvant gemcitabine and cisplatin in muscle-invasive bladder cancer. J Oncol Pharm Pract. 2020 Mar;26(2):330–7.Full Text Open Access Copy Link to Item
-
Sloan FA, Yashkin AP, Akushevich I, Inman BA. Longitudinal patterns of cost and utilization of medicare beneficiaries with bladder cancer. Urol Oncol. 2020 Feb;38(2):39.e11-39.e19.Full Text Open Access Copy Link to Item
-
Tan WP, Longo TA, Inman BA. Heated Intravesical Chemotherapy: Biology and Clinical Utility. Urol Clin North Am. 2020 Feb;47(1):55–72.Full Text Open Access Copy Link to Item
-
Chiang RS, Connor AA, Inman BA, Foo W-C, Howell DN, Madden JF, et al. Metastatic Urothelial Carcinoma from Transplanted Kidney with Complete Response to an Immune Checkpoint Inhibitor. Case Rep Urol. 2020;2020:8881841.Full Text Open Access Copy Link to Item
-
Tan WP, Chang A, Brousell SC, Grimberg DC, Fantony JJ, Longo TA, et al. Safety and efficacy of intravesical chemotherapy and hyperthermia in the bladder: results of a porcine study. Int J Hyperthermia. 2020;37(1):854–60.Full Text Open Access Copy Link to Item
-
VanDusen KW, Eleswarpu S, Moretti EW, Devinney MJ, Crabtree DM, Laskowitz DT, et al. The MARBLE Study Protocol: Modulating ApoE Signaling to Reduce Brain Inflammation, DeLirium, and PostopErative Cognitive Dysfunction. J Alzheimers Dis. 2020;75(4):1319–28.Full Text Open Access Copy Link to Item
-
Apolo AB, Milowsky MI, Kim L, Inman BA, Kamat AM, Steinberg G, et al. Eligibility and Radiologic Assessment in Adjuvant Clinical Trials in Bladder Cancer. Jama Oncol. 2019 Dec 1;5(12):1790–8.Full Text Link to Item
-
Tan WP, Tan WS, Inman BA. PD-L1/PD-1 Biomarker for Metastatic Urothelial Cancer that Progress Post-platinum Therapy: A Systematic Review and Meta-analysis. Bladder Cancer. 2019 Nov 22;5(3):211–23.Full Text Open Access Copy Link to Item
-
Berger M, Murdoch DM, Staats JS, Chan C, Thomas JP, Garrigues GE, et al. Flow Cytometry Characterization of Cerebrospinal Fluid Monocytes in Patients With Postoperative Cognitive Dysfunction: A Pilot Study. Anesth Analg. 2019 Nov;129(5):e150–4.Full Text Open Access Copy Link to Item
-
Lotan Y, Inman BA, Davis LG, Kassouf W, Messing E, Daneshmand S, et al. Evaluation of the Fluorescence In Situ Hybridization Test to Predict Recurrence and/or Progression of Disease after bacillus Calmette-Guérin for Primary High Grade Nonmuscle Invasive Bladder Cancer: Results from a Prospective Multicenter Trial. J Urol. 2019 Nov;202(5):920–6.Full Text Open Access Copy Link to Item
-
Freedland SJ, Howard L, Allen J, Smith J, Stout J, Aronson W, et al. A lifestyle intervention of weight loss via a low-carbohydrate diet plus walking to reduce metabolic disturbances caused by androgen deprivation therapy among prostate cancer patients: carbohydrate and prostate study 1 (CAPS1) randomized controlled trial. Prostate Cancer Prostatic Dis. 2019 Sep;22(3):428–37.Full Text Open Access Copy Link to Item
-
Soria F, Krabbe L-M, Todenhöfer T, Dobruch J, Mitra AP, Inman BA, et al. Molecular markers in bladder cancer. World J Urol. 2019 Jan;37(1):31–40.Full Text Link to Item
-
Dunkman WJ, Manning MW, Whittle J, Hunting J, Rampersaud EN, Inman BA, et al. Impact of an enhanced recovery pathway on length of stay and complications in elective radical cystectomy: a before and after cohort study. Perioper Med (Lond). 2019;8:9.Full Text Open Access Copy Link to Item
-
Terlecki RP, Miller NL, Inman BA. Trends in Urological Referral Patterns: A Study of Community and University Urologists in the United States. Urology Practice. 2018 Nov 1;5(6):480–8.Full Text
-
Ingersoll MA, Li X, Inman BA, Greiner JW, Black PC, Adam RM. Immunology, Immunotherapy, and Translating Basic Science into the Clinic for Bladder Cancer. Bladder Cancer. 2018 Oct 29;4(4):429–40.Full Text Link to Item
-
Gopalakrishna A, Chang A, Longo TA, Fantony JJ, Harrison MR, Wischmeyer PE, et al. Dietary patterns and health-related quality of life in bladder cancer survivors. Urol Oncol. 2018 Oct;36(10):469.e21-469.e29.Full Text Link to Item
-
Flaig TW, Spiess PE, Agarwal N, Bangs R, Boorjian SA, Buyyounouski MK, et al. NCCN Guidelines Insights: Bladder Cancer, Version 5.2018. J Natl Compr Canc Netw. 2018 Sep;16(9):1041–53.Full Text Link to Item
-
Liem EIML, McCormack M, Chan ESY, Matsui Y, Geavlete P, Choi YD, et al. Monopolar vs. bipolar transurethral resection for non-muscle invasive bladder carcinoma: A post-hoc analysis from a randomized controlled trial. Urol Oncol. 2018 Jul;36(7):338.e1-338.e11.Full Text Link to Item
-
Aminsharifi A, Brousell SC, Chang A, León J, Inman BA. Heat-targeted drug delivery: A promising approach for organsparing treatment of bladder cancer.THERMODOX®. Arch Esp Urol. 2018 May;71(4):447–52.Link to Item
-
Vo-Dinh T, Inman BA. What potential does plasmonics-amplified synergistic immuno photothermal nanotherapy have for treatment of cancer? Nanomedicine (Lond). 2018 Jan;13(2):139–44.Full Text Link to Item
-
Brousell SC, Fantony JJ, Van Noord MG, Harrison MR, Inman BA. Vinflunine for the treatment of advanced or metastatic transitional cell carcinoma of the urothelial tract: an evidence-based review of safety, efficacy, and place in therapy. Core Evid. 2018;13:1–12.Full Text Link to Item
-
Fonteyne V, Ost P, Bellmunt J, Droz JP, Mongiat-Artus P, Inman B, et al. Curative Treatment for Muscle Invasive Bladder Cancer in Elderly Patients: A Systematic Review. Eur Urol. 2018 Jan;73(1):40–50.Full Text Link to Item
-
Shore ND, Boorjian SA, Canter DJ, Ogan K, Karsh LI, Downs TM, et al. Intravesical rAd-IFNα/Syn3 for Patients With High-Grade, Bacillus Calmette-Guerin-Refractory or Relapsed Non-Muscle-Invasive Bladder Cancer: A Phase II Randomized Study. J Clin Oncol. 2017 Oct 20;35(30):3410–6.Full Text Link to Item
-
Spiess PE, Agarwal N, Bangs R, Boorjian SA, Buyyounouski MK, Clark PE, et al. Bladder Cancer, Version 5.2017, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2017 Oct;15(10):1240–67.Full Text Link to Item
-
Gopalakrishna A, Longo TA, Fantony JJ, Harrison MR, Inman BA. Physical activity patterns and associations with health-related quality of life in bladder cancer survivors. Urol Oncol. 2017 Sep;35(9):540.e1-540.e6.Full Text Link to Item
-
Liu Y, Maccarini P, Palmer GM, Etienne W, Zhao Y, Lee C-T, et al. Synergistic Immuno Photothermal Nanotherapy (SYMPHONY) for the Treatment of Unresectable and Metastatic Cancers. Sci Rep. 2017 Aug 17;7(1):8606.Full Text Open Access Copy Link to Item
-
Leone A, Inman B, Spiess PE. Need for Evidence and Consensus on Laser Treatment for Management of Select Primary Penile Tumors. Eur Urol. 2017 Jul;72(1):4–6.Full Text Link to Item
-
Gopalakrishna A, Fantony JJ, Longo TA, Owusu R, Foo W-C, Dash R, et al. Anticipatory Positive Urine Tests for Bladder Cancer. Ann Surg Oncol. 2017 Jun;24(6):1747–53.Full Text Link to Item
-
Furuya H, Rosser CJ, Inman BA, Fantony JJ. Reply to 'It May be Time to Abandon Urine Tests for Bladder Cancer'. J Natl Compr Canc Netw. 2017 May;15(5):lxx–lxxii.Full Text Link to Item
-
Inman BA, Fantony JJ. Authors' reply to letter to editor: "reply to 'it may be time to abandon urine tests for bladder cancer'". Jnccn Journal of the National Comprehensive Cancer Network. 2017 May 1;15(5):lxxi–lxxii.
-
Inman BA, Longo TA, Ramalingam S, Harrison MR. Atezolizumab: A PD-L1-Blocking Antibody for Bladder Cancer. Clin Cancer Res. 2017 Apr 15;23(8):1886–90.Full Text Link to Item
-
Fantony JJ, Longo TA, Gopalakrishna A, Owusu R, Lance RS, Foo W-C, et al. Urinary NID2 and TWIST1 methylation to augment conventional urine cytology for the detection of bladder cancer. Cancer Biomark. 2017;18(4):381–7.Full Text Link to Item
-
Giattino CM, Gardner JE, Sbahi FM, Roberts KC, Cooter M, Moretti E, et al. Intraoperative Frontal Alpha-Band Power Correlates with Preoperative Neurocognitive Function in Older Adults. Front Syst Neurosci. 2017;11:24.Full Text Open Access Copy Link to Item
-
Longo T, McGinley KF, Freedman JA, Etienne W, Wu Y, Sibley A, et al. Targeted Exome Sequencing of the Cancer Genome in Patients with Very High-risk Bladder Cancer. Eur Urol. 2016 Nov;70(5):714–7.Full Text Link to Item
-
Clark PE, Spiess PE, Agarwal N, Bangs R, Boorjian SA, Buyyounouski MK, et al. NCCN Guidelines Insights: Bladder Cancer, Version 2.2016. J Natl Compr Canc Netw. 2016 Oct;14(10):1213–24.Full Text Link to Item
-
Gopalakrishna A, Longo TA, Fantony JJ, Van Noord M, Inman BA. Lifestyle factors and health-related quality of life in bladder cancer survivors: a systematic review. J Cancer Surviv. 2016 Oct;10(5):874–82.Full Text Link to Item
-
Gopalakrishna A, Longo TA, Fantony JJ, Doshi U, Harrison MR, Van Noord M, et al. High rates of venous thromboembolic events in patients undergoing systemic therapy for urothelial carcinoma: A systematic review and meta-analysis. Urol Oncol. 2016 Sep;34(9):407–14.Full Text Link to Item
-
Gopalakrishna A, Longo TA, Fantony JJ, Owusu R, Foo W-C, Dash R, et al. The diagnostic accuracy of urine-based tests for bladder cancer varies greatly by patient. Bmc Urol. 2016 Jun 13;16(1):30.Full Text Link to Item
-
Crezee H, Inman BA. The use of hyperthermia in the treatment of bladder cancer. Int J Hyperthermia. 2016 Jun;32(4):349–50.Full Text Link to Item
-
Fantony JJ, Gopalakrishna A, Noord MV, Inman BA. Reporting Bias Leading to Discordant Venous Thromboembolism Rates in the United States Versus Non-US Countries Following Radical Cystectomy: A Systematic Review and Meta-analysis. Eur Urol Focus. 2016 Jun;2(2):189–96.Full Text Link to Item
-
Longo TA, Gopalakrishna A, Tsivian M, Van Noord M, Rasch CR, Inman BA, et al. A systematic review of regional hyperthermia therapy in bladder cancer. Int J Hyperthermia. 2016 Jun;32(4):381–9.Full Text Link to Item
-
Sylvester RJ, Oosterlinck W, Holmang S, Sydes MR, Birtle A, Gudjonsson S, et al. Systematic Review and Individual Patient Data Meta-analysis of Randomized Trials Comparing a Single Immediate Instillation of Chemotherapy After Transurethral Resection with Transurethral Resection Alone in Patients with Stage pTa-pT1 Urothelial Carcinoma of the Bladder: Which Patients Benefit from the Instillation? Eur Urol. 2016 Feb;69(2):231–44.Full Text Link to Item
-
Fantony JJ, Abern MR, Gopalakrishna A, Owusu R, Jack Tay K, Lance RS, et al. Multi-institutional external validation of urinary TWIST1 and NID2 methylation as a diagnostic test for bladder cancer. Urol Oncol. 2015 Sep;33(9):387.e1-387.e6.Full Text Link to Item
-
Fantony JJ, Inman BA. It May Be Time to Abandon Urine Tests for Bladder Cancer. J Natl Compr Canc Netw. 2015 Sep;13(9):1163–6.Full Text Link to Item
-
Seideman C, Canter D, Kim P, Cordon B, Weizer A, Oliva I, et al. Multicenter evaluation of the role of UroVysion FISH assay in surveillance of patients with bladder cancer: does FISH positivity anticipate recurrence? World J Urol. 2015 Sep;33(9):1309–13.Full Text Link to Item
-
Inman B, Tay KJ. Inflammation: A Significant Contributor to Upper-tract Urothelial Carcinoma Prognosis? Eur Urol Focus. 2015 Aug;1(1):64–5.Full Text Link to Item
-
Glass OK, Inman BA, Broadwater G, Courneya KS, Mackey JR, Goruk S, et al. Effect of aerobic training on the host systemic milieu in patients with solid tumours: an exploratory correlative study. Br J Cancer. 2015 Mar 3;112(5):825–31.Full Text Link to Item
-
Fantony JJ, Inman BA. Thromboembolism and bleeding in bladder cancer. Oncology (Williston Park). 2014 Oct;28(10):847–54.Open Access Copy Link to Item
-
Inman BA, Stauffer PR, Craciunescu OA, Maccarini PF, Dewhirst MW, Vujaskovic Z. A pilot clinical trial of intravesical mitomycin-C and external deep pelvic hyperthermia for non-muscle-invasive bladder cancer. Int J Hyperthermia. 2014 May;30(3):171–5.Full Text Link to Item
-
Juang T, Stauffer PR, Craciunescu OA, Maccarini PF, Yuan Y, Das SK, et al. Thermal dosimetry characteristics of deep regional heating of non-muscle invasive bladder cancer. Int J Hyperthermia. 2014 May;30(3):176–83.Full Text Link to Item
-
Sousa A, Inman BA, Piñeiro I, Monserrat V, Pérez A, Aparici V, et al. A clinical trial of neoadjuvant hyperthermic intravesical chemotherapy (HIVEC) for treating intermediate and high-risk non-muscle invasive bladder cancer. Int J Hyperthermia. 2014 May;30(3):166–70.Full Text Link to Item
-
Abern MR, Owusu R, Inman BA. Clinical performance and utility of a DNA methylation urine test for bladder cancer. Urol Oncol. 2014 Jan;32(1):51.e21-51.e26.Full Text Link to Item
-
Roy SL, Metzger R, Chen JG, Laham FR, Martin M, Kipper SW, et al. Risk for transmission of Naegleria fowleri from solid organ transplantation. Am J Transplant. 2014 Jan;14(1):163–71.Full Text Link to Item
-
Oliveira TR, Stauffer PR, Lee C-T, Landon CD, Etienne W, Ashcraft KA, et al. Magnetic fluid hyperthermia for bladder cancer: a preclinical dosimetry study. Int J Hyperthermia. 2013 Dec;29(8):835–44.Full Text Link to Item
-
Crowgey TR, Inman B, Gan TJ. Utility of preoperative echocardiograms in patients receiving treatment for bladder cancer. a retrospective study. Journal of Anesthesia and Clinical Research. 2013 Jun 1;4(6).Full Text
-
Inman BA, Etienne W, Rubin R, Owusu RA, Oliveira TR, Rodriques DB, et al. The impact of temperature and urinary constituents on urine viscosity and its relevance to bladder hyperthermia treatment. Int J Hyperthermia. 2013 May;29(3):206–10.Full Text Link to Item
-
Inman BA, Harrison MR, George DJ. Novel immunotherapeutic strategies in development for renal cell carcinoma. Eur Urol. 2013 May;63(5):881–9.Full Text Link to Item
-
Abern MR, Owusu RA, Anderson MR, Rampersaud EN, Inman BA. Perioperative intravesical chemotherapy in non-muscle-invasive bladder cancer: a systematic review and meta-analysis. J Natl Compr Canc Netw. 2013 Apr 1;11(4):477–84.Full Text Link to Item
-
Wang AJ, Goldsmith ZG, Neisius A, Astroza GM, Oredein-McCoy O, Iqbal MW, et al. Increasing dwell time of mitomycin C in the upper tract with a reverse thermosensitive polymer. J Endourol. 2013 Mar;27(3):288–93.Full Text Link to Item
-
Owusu RA, Abern MR, Inman BA. Hyperthermia as adjunct to intravesical chemotherapy for bladder cancer. Biomed Res Int. 2013;2013:262313.Full Text Link to Item
-
Underwood DJ, Zhang J, Denton BT, Shah ND, Inman BA. Simulation optimization of PSA-threshold based prostate cancer screening policies. Health Care Manag Sci. 2012 Dec;15(4):293–309.Full Text Link to Item
-
Zhang J, Denton BT, Balasubramanian H, Shah ND, Inman BA. Optimization of prostate biopsy referral decisions. Manufacturing and Service Operations Management. 2012 Sep 1;14(4):529–47.Full Text
-
Cloutier J, Aziz A, Inman B, Bolduc S. Bilateral renal cell carcinoma in a child. Urology. 2012 Aug;80(2):430–3.Full Text Link to Item
-
Inman BA, Zhang J, Shah ND, Denton BT. An examination of the dynamic changes in prostate-specific antigen occurring in a population-based cohort of men over time. Bju Int. 2012 Aug;110(3):375–81.Full Text Link to Item
-
Frigola X, Inman BA, Krco CJ, Liu X, Harrington SM, Bulur PA, et al. Soluble B7-H1: differences in production between dendritic cells and T cells. Immunol Lett. 2012 Feb 29;142(1–2):78–82.Full Text Link to Item
-
Banez LL, Davidson AK, Etienne W, Allott EH, Calloway EE, Inman BA. The effect of acute and chronic exposure to acetaldehyde-a mutagenic metabolite of dietary ethanol-on prostate cancer cells: A potential source of race disparity disfavoring black men. J Clin Oncol. 2012 Feb 10;30(5_suppl):143.Link to Item
-
Banez LL, Davidson AK, Etienne W, Allott EH, Calloway EE, Inman BA. The effect of acute and chronic exposure to acetaldehyde-a mutagenic metabolite of dietary ethanol-on prostate cancer cells: A potential source of race disparity disfavoring black men. J Clin Oncol. 2012 Feb 10;30(5_suppl):143.Full Text Link to Item
-
Salahi S, Maccarini PF, Rodrigues DB, Etienne W, Landon CD, Inman BA, et al. Miniature microwave applicator for murine bladder hyperthermia studies. Int J Hyperthermia. 2012;28(5):456–65.Full Text Link to Item
-
Inman BA, Frank I, Boorjian SA, Akornor JW, Karnes RJ, Leibovich BC, et al. Dynamic prediction of metastases after radical prostatectomy for prostate cancer. Bju Int. 2011 Dec;108(11):1762–8.Full Text Link to Item
-
Lammers RJM, Witjes JA, Inman BA, Leibovitch I, Laufer M, Nativ O, et al. The role of a combined regimen with intravesical chemotherapy and hyperthermia in the management of non-muscle-invasive bladder cancer: a systematic review. Eur Urol. 2011 Jul;60(1):81–93.Full Text Link to Item
-
Morse MA, Bradley DA, Keler T, Laliberte RJ, Green JA, Davis TA, et al. CDX-1307: a novel vaccine under study as treatment for muscle-invasive bladder cancer. Expert Rev Vaccines. 2011 Jun;10(6):733–42.Full Text Link to Item
-
Frigola X, Inman BA, Lohse CM, Krco CJ, Cheville JC, Thompson RH, et al. Identification of a soluble form of B7-H1 that retains immunosuppressive activity and is associated with aggressive renal cell carcinoma. Clin Cancer Res. 2011 Apr 1;17(7):1915–23.Full Text Link to Item
-
Raymundo EM, Lipkin ME, Bañez LB, Mancini JG, Zilberman DE, Preminger GM, et al. Third prize: the role of endoscopic nephron-sparing surgery in the management of upper tract urothelial carcinoma. J Endourol. 2011 Mar;25(3):377–84.Full Text Link to Item
-
Rampersaud EN, Vujaskovic Z, Inman BA. Hyperthermia as a treatment for bladder cancer. Oncology (Williston Park). 2010 Nov 15;24(12):1149–55.Link to Item
-
Jones LW, Douglas PS, Eves ND, Marcom PK, Kraus WE, Herndon JE, et al. Rationale and design of the Exercise Intensity Trial (EXCITE): A randomized trial comparing the effects of moderate versus moderate to high-intensity aerobic training in women with operable breast cancer. Bmc Cancer. 2010 Oct 6;10:531.Full Text Open Access Copy Link to Item
-
Stewart SB, Leder RA, Inman BA. Imaging tumors of the penis and urethra. Urol Clin North Am. 2010 Aug;37(3):353–67.Full Text Link to Item
-
Routh JC, Inman BA, Reinberg Y. Dextranomer/hyaluronic acid for pediatric vesicoureteral reflux: systematic review. Pediatrics. 2010 May;125(5):1010–9.Full Text Link to Item
-
Inman BA, Tran V-T, Fradet Y, Lacombe L. Carcinoma of the upper urinary tract: predictors of survival and competing causes of mortality. Cancer. 2009 Jul 1;115(13):2853–62.Full Text Link to Item
-
Bolduc S, Inman BA, Lacombe L, Fradet Y, Tremblay RR. Early detection of prostate cancer local recurrence by urinary prostate-specific antigen. Can Urol Assoc J. 2009 Jun;3(3):213–7.Full Text Link to Item
-
Magera JS, Inman BA, Elliott DS. Outcome analysis of urethral wall stent insertion with artificial urinary sphincter placement for severe recurrent bladder neck contracture following radical prostatectomy. J Urol. 2009 Mar;181(3):1236–41.Full Text Link to Item
-
KWON EUGENE D, CHEVILLE JOHN C, SEBO THOMAS J, INMAN BRANT A. METHODS FOR REDUCING GRANULOMATOUS INFLAMMATION. 2009 Feb 27;
-
KWON EUGENE D, CHEVILLE JOHN C, SEBO THOMAS J, INMAN BRANT A. METHODS FOR REDUCING GRANULOMATOUS INFLAMMATION. 2009 Feb 27;
-
KWON EUGENE D, DONG HAIDONG, BARO XAVIER FRIGOLA, INMAN BRANT A. Soluble B7-H1. 2008 Oct 20;
-
Inman BA, Davies JD, Rangel LJ, Bergstralh EJ, Kwon ED, Blute ML, et al. Long-term outcomes of radical prostatectomy with multimodal adjuvant therapy in men with a preoperative serum prostate-specific antigen level > or =50 ng/mL. Cancer. 2008 Oct 1;113(7):1544–51.Full Text Link to Item
-
Inman BA, Myers RP. Is the location of a positive surgical margin after radical prostatectomy important for prognosis? Nat Clin Pract Urol. 2008 Sep;5(9):476–7.Full Text Link to Item
-
Routh JC, Inman BA, Ashley RA, Vandersteen DR, Reinberg Y, Wolpert JJ, et al. Unilateral vesicoureteral reflux: does endoscopic injection based on the cystoscopic appearance of the ureteral orifice decrease the incidence of de-novo contralateral reflux? J Pediatr Urol. 2008 Aug;4(4):260–4.Full Text Link to Item
-
Roth TJ, Vandersteen DR, Hollatz P, Inman BA, Reinberg YE. Sacral neuromodulation for the dysfunctional elimination syndrome: a single center experience with 20 children. J Urol. 2008 Jul;180(1):306–11.Full Text Link to Item
-
Ashley RA, Inman BA, Routh JC, Mynderse LA, Gettman MT, Blute ML. Reassessing the diagnostic yield of saturation biopsy of the prostate. Eur Urol. 2008 May;53(5):976–81.Full Text Link to Item
-
Siddiqui SA, Boorjian SA, Inman B, Bagniewski S, Bergstralh EJ, Blute ML. Timing of androgen deprivation therapy and its impact on survival after radical prostatectomy: a matched cohort study. J Urol. 2008 May;179(5):1830–7.Full Text Link to Item
-
Inman BA, Frigola X, Harris KJ, Kuntz SM, Lohse CM, Leibovich BC, et al. Questionable relevance of gamma delta T lymphocytes in renal cell carcinoma. J Immunol. 2008 Mar 1;180(5):3578–84.Full Text Link to Item
-
Routh JC, Kramer SA, Inman BA, Ashley RA, Wolpert JJ, Vandersteen DR, et al. Utility of dextranomer/hyaluronic acid injection in setting of bladder and ureteral anomalies. Urology. 2008 Mar;71(3):435–8.Full Text Link to Item
-
Magera JS, Inman BA, Slezak JM, Bagniewski SM, Sebo TJ, Myers RP. Increased optical magnification from 2.5x to 4.3x with technical modification lowers the positive margin rate in open radical retropubic prostatectomy. J Urol. 2008 Jan;179(1):130–5.Full Text Link to Item
-
Sengupta S, Blute ML, Bagniewski SM, Inman B, Leibovich BC, Slezak JM, et al. After radical retropubic prostatectomy 'insignificant' prostate cancer has a risk of progression similar to low-risk 'significant' cancer. Bju Int. 2008 Jan;101(2):170–4.Full Text Link to Item
-
Boorjian SA, Frank I, Inman B, Lohse CM, Cheville JC, Leibovich BC, et al. The role of partial nephrectomy for the management of sporadic renal angiomyolipoma. Urology. 2007 Dec;70(6):1064–8.Full Text Link to Item
-
Ashley RA, Inman BA, Routh JC, Krambeck AE, Siddiqui SA, Mynderse LA, et al. Preventing pain during office biopsy of the prostate: a single center, prospective, double-blind, 3-arm, parallel group, randomized clinical trial. Cancer. 2007 Oct 15;110(8):1708–14.Full Text Link to Item
-
Ashley RA, Inman BA, Routh JC, Rohlinger AL, Husmann DA, Kramer SA. Urachal anomalies: a longitudinal study of urachal remnants in children and adults. J Urol. 2007 Oct;178(4 Pt 2):1615–8.Full Text Link to Item
-
Magera JS, Inman BA, Elliott DS. Does preoperative topical antimicrobial scrub reduce positive surgical site culture rates in men undergoing artificial urinary sphincter placement? J Urol. 2007 Oct;178(4 Pt 1):1328–32.Full Text Link to Item
-
Routh JC, Reinberg Y, Ashley RA, Inman BA, Wolpert JJ, Vandersteen DR, et al. Multivariate comparison of the efficacy of intraureteral versus subtrigonal techniques of dextranomer/hyaluronic acid injection. J Urol. 2007 Oct;178(4 Pt 2):1702–5.Full Text Link to Item
-
Webster WS, Thompson RH, Harris KJ, Frigola X, Kuntz S, Inman BA, et al. Targeting molecular and cellular inhibitory mechanisms for improvement of antitumor memory responses reactivated by tumor cell vaccine. J Immunol. 2007 Sep 1;179(5):2860–9.Full Text Link to Item
-
Roth TJ, Sheinin Y, Lohse CM, Kuntz SM, Frigola X, Inman BA, et al. B7-H3 ligand expression by prostate cancer: a novel marker of prognosis and potential target for therapy. Cancer Res. 2007 Aug 15;67(16):7893–900.Full Text Link to Item
-
Inman BA, Sebo TJ, Frigola X, Dong H, Bergstralh EJ, Frank I, et al. PD-L1 (B7-H1) expression by urothelial carcinoma of the bladder and BCG-induced granulomata: associations with localized stage progression. Cancer. 2007 Apr 15;109(8):1499–505.Full Text Link to Item
-
Inman BA, Frigola X, Dong H, Kwon ED. Costimulation, coinhibition and cancer. Curr Cancer Drug Targets. 2007 Feb;7(1):15–30.Full Text Link to Item
-
Inman BA, DiMarco DS, Slezak JM, Sebo TJ, Kwon ED, Leibovich BC, et al. Outcomes of Gleason score 10 prostate carcinoma treated by radical prostatectomy. Urology. 2006 Sep;68(3):604–8.Full Text Link to Item
-
Ashley RA, Inman BA, Sebo TJ, Leibovich BC, Blute ML, Kwon ED, et al. Urachal carcinoma: clinicopathologic features and long-term outcomes of an aggressive malignancy. Cancer. 2006 Aug 15;107(4):712–20.Full Text Link to Item
-
Siddiqui SA, Inman BA, Sengupta S, Slezak JM, Bergstralh EJ, Leibovich BC, et al. Obesity and survival after radical prostatectomy: A 10-year prospective cohort study. Cancer. 2006 Aug 1;107(3):521–9.Full Text Link to Item
-
Inman BA, Harel F, Audet J-F, Meyer F, Douville P, Fradet Y, et al. Insulin-like growth factor binding protein 2: an androgen-dependent predictor of prostate cancer survival. Eur Urol. 2005 May;47(5):695–702.Full Text Link to Item
-
Inman BA, Harel F, Tiguert R, Lacombe L, Fradet Y. Routine nasogastric tubes are not required following cystectomy with urinary diversion: a comparative analysis of 430 patients. J Urol. 2003 Nov;170(5):1888–91.Full Text Link to Item
-
Inman B, Halloran B, Melk A, Ramassar V, Halloran PF. Microchimerism in sensitized renal patients. Transplantation. 1999 May 27;67(10):1381–3.Full Text Link to Item
-
Atchia K, Joncas F-H, Trasiewicz LS, Tan WP, Ding K, Inman BA, et al. Follicle-Stimulating Hormone (FSH) Levels During Androgen Deprivation Therapy Are Not Associated With Survival or Development of Castration-Resistant Prostate Cancer. Soc Int Urol J. 3(2):56–61.Full Text Open Access Copy Link to Item
-
Grimberg D, Shah A, Tan WP, Etienne W, Spasojevic I, Inman B. Hyperthermia Improves Solubility of Intravesical Chemotherapeutic Agents. Bladder Cancer. Preprint:1–10.Full Text Open Access Copy Link to Item
-
-
Book Sections
-
Kramer MW, Cash H, Inman BA. Bladder cancer. In: Urology at a Glance. 2014. p. 151–5.Full Text
-
Protzel C, Hakenberg OW, Inman BA. Penile cancer. In: Urology at a Glance. 2014. p. 305–10.Full Text
-
Inman BA, Stewart SB, Kattan MW. Staging and risk stratification in penile cancer. In: Spiess PE, editor. Penile Cancer. Humana PressInc; 2013. p. 11–42.
-
Blute ML, Inman BA. Anatomy and principles of renal surgery. In: Jr JAS, Howards SS, Preminger GM, editors. Hinman’s Atlas of Urologic Surgery. Elsevier Health Sciences; 2012. p. 967–74.
-
Blute ML, Inman BA. Simple nephrectomy. In: Jr JAS, Howards SS, Preminger GM, editors. Hinman’s Atlas of Urologic Surgery. Elsevier Health Sciences; 2012. p. 975–88.
-
Blute ML, Inman BA. Radical nephrectomy. In: Jr JAS, Howards SS, Preminger GM, editors. Hinman’s Atlas of Urologic Surgery. Elsevier Health Sciences; 2012. p. 989–1000.
-
Blute ML, Inman BA. Partial nephrectomy. In: Jr JAS, Howards SS, Preminger GM, editors. Hinman’s Atlas of Urologic Surgery. Elsevier Health Sciences; 2012. p. 1001–8.
-
Blute ML, Inman BA. Nephroureterectomy. In: Jr JAS, Howards SS, Preminger GM, editors. Hinman’s Atlas of Urologic Surgery. Elsevier Health Sciences; 2012. p. 1009–21.
-
Blute ML, Inman BA. Extracorporeal renal surgery. In: Jr JAS, Howards SS, Preminger GM, editors. Hinman’s Atlas of Urologic Surgery. Elsevier Health Sciences; 2012. p. 1021–4.
-
Blute ML, Inman BA. Vena caval thrombectomy. In: Jr JAS, Howards SS, Preminger GM, editors. Hinman’s Atlas of Urologic Surgery. Elsevier Health Sciences; 2012. p. 1025–42.
-
Inman BA, Frigola X, Dong H, Yang JC, Kwon ED. Restoring host antitumoral immunity: how coregulatory molecules are changing the approach to the management of renal cell carcinoma. In: Bukowski RM, Figlin RA, Motzer R, editors. Renal Cell Carcinoma. Humana Press; 2009. p. 367–434.
-
Inman BA, Blute ML, Hartman RP. Urothelial Cell Carcinoma of the Upper Urinary Tract: Introduction. In: Rosette JJMCH, Manyak MJ, Harisinghani MG, Wijkstra H, editors. Imaging in Oncological Urology. Springer; 2008. p. 115–20.
-
Inman BA, Leibovich BC. Therapeutic counseling for the medical management of renal cell carcinoma. In: Rosette JJMCH, Sternberg CN, Poppel HPV, editors. Renal Cell Cancer: Diagnosis and Therapy. Springer; 2008. p. 515–34.
-
-
Other Articles
-
Inman BA. Words of wisdom. Re: final results of an EORTC-GU cancers group randomized study of maintenance bacillus Calmette-Guérin in intermediate- and high-risk Ta, T1 papillary carcinoma of the urinary bladder: one-third dose versus full dose and 1 year versus 3 years of maintenance. Vol. 64, Eur Urol. 2013. p. 171–2.Full Text Link to Item
-
Oliveira TR, Stauffer PR, Lee C-T, Landon C, Etienne W, Maccarini PF, et al. Preclinical Dosimetry of Magnetic Fluid Hyperthermia for Bladder Cancer. Vol. 8584, Proc Spie Int Soc Opt Eng. 2013. p. 1656985.Full Text Link to Item
-
Abern MR, Freedland SJ, Inman BA. Obesity is associated with worse oncological outcomes in patients treated with radical cystectomy. Vol. 111, Bju Int. 2013. p. 187–8.Full Text Link to Item
-
Inman BA. Open versus laparoscopic nephroureterectomy: is there really a debate? Vol. 61, Eur Urol. 2012. p. 722–3.Full Text Link to Item
-
Inman BA, George DJ. Is tumor response important for renal carcinoma? Vol. 59, Eur Urol. 2011. p. 16–7.Full Text Link to Item
-
Inman BA, St Sauver JL, Jacobson DJ, McGree ME, Nehra A, Lieber MM, et al. A population-based, longitudinal study of erectile dysfunction and future coronary artery disease. Vol. 64, Obstetrical and Gynecological Survey. 2009. p. 459–60.Full Text
-
Sauver JLS, Jacobson DJ, Nehra A, Inman BA, Jacobsen SJ. Obstructive Sleep Apnea Associated With Erectile Dysfunction and Cardiovascular Disease–Reply–I. Vol. 84, Mayo Clinic Proceedings. 2009. p. 562–562.Full Text
-
Inman BA. Editorial Comment. Vol. 181, Journal of Urology. 2009. p. 591.Full Text
-
Inman BA. Effects of Curcumin in an Orthotopic Murine Bladder Tumor Model EDITORIAL COMMENT. Vol. 35, International Braz J Urol. 2009. p. 607–607.Link to Item
-
Inman BA, Reinberg Y. Editorial Comment. Vol. 72, Urology. 2008. p. 538.Full Text
-
Routh JC, Inman BA, Reinberg Y. Re: Endoscopic treatment of vesicoureteral reflux associated with paraureteral diverticula in children. W. H. Cerwinka, H. C. Scherz and A. J. Kirsch. J Urol 2007; 178: 1469-1473. Vol. 179, J Urol. 2008. p. 1205.Full Text Link to Item
-
Inman BA, Blute ML. Editorial Comment. Vol. 179, Journal of Urology. 2008. p. 161–2.Full Text
-
Inman BA. Editorial Comment. Vol. 180, Journal of Urology. 2008. p. 902–3.Full Text
-
Inman BA, Myers RP. Re: Saturation technique does not improve cancer detection as an initial prostate biopsy strategy. J. S. Jones, A. Patel, L. Schoenfield, J. C. Rabets, C. D. Zippe and C. Magi-Galluzzi. J Urol, 175: 485-488, 2006. Vol. 176, J Urol. 2006. p. 1252–3.Full Text Link to Item
- Full Text Link to Item
-
Inman BA, Leibovich BC. Editorial Comment. Vol. 176, Journal of Urology. 2006. p. 1337–8.Full Text
-
Tiguert R, Inman BA. Re: Pretreatment total testosterone level predicts pathological stage in patients with localized prostate cancer treated with radical prostatectomy. Vol. 170, J Urol. 2003. p. 2392.Full Text Link to Item
-
-
Conference Papers
-
Patierno BM, Foo W-C, Allen T, Somarelli JA, Ware KE, Gupta S, et al. Characterization of a castrate-resistant prostate cancer xenograft derived from a patient of West African ancestry. In: Prostate Cancer Prostatic Dis. 2021.Full Text Open Access Copy Link to Item
-
Inman BA, Balar AV, Milowsky MI, Pruthi RS, Polasek MJ, Morris SR, et al. LUMINOS-103: A basket trial evaluating the safety and efficacy of PVSRIPO in patients with advanced solid tumors. In: Cancer Research. 2021.Link to Item
-
Narayan V, Boorjian S, Alemozaffer M, Konety BR, Gomella L, Kamat AM, et al. Subgroup analyses of the phase 3 study of intravesical nadofaragene firadenovec in patients with high-grade, BCG-unresponsive Non-Muscle Invasive Bladder Cancer (NMIBC). In: European Urology. 2021. p. S1026–7.Link to Item
-
Narayan V, Boorjian S, Alemozaffer M, Konety BR, Gomella L, Kamat AM, et al. Significant anti-adenovirus antibody response positively correlates with efficacy in patients treated with nadofaragene firadenovec for high-grade BCG-unresponsive Non-Muscle Invasive Bladder Cancer (NMIBC). In: European Urology. 2021. p. S1028–9.Link to Item
-
Grimberg DC, Campbell SP, Etienne W, Fan P, Maccarini PF, Spasojevic I, et al. Hyperthermia, bladder pressure, and intravesical drug delivery. In: Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2021. p. 469–469.Full Text
-
Liu Y, Maccarini P, Palmer GM, Inman BA, Fecci PE, Vo-Dinh T. Abstract 6630: Synergistic immuno photothermal nanotherapy (SYMPHONY) for combination cancer therapy. In: Cancer Research. American Association for Cancer Research (AACR); 2020. p. 6630–6630.Full Text
-
Cupil-Garcia V, Liu Y, Crawford BM, Chongsathidkiet P, Palmer G, Maccarini P, et al. Nanostar probes: A golden platform for Synergistic Immuno Photothermal Nanotherapy (SYMPHONY) for the treatment of metastatic cancer. In: Progress in Biomedical Optics and Imaging Proceedings of Spie. 2020.Full Text
-
Tan WP, Chang A, Barton G, Etienne W, Inman B. The effect of conductive hyperthermia on mitomycin C absorption during intravesical chemotherapy. In: International Journal of Urology. WILEY; 2019. p. 83–83.Link to Item
-
Tan WP, Liu Y, Maccarini P, Palmer G, Barton G, Etienne W, et al. Synergistic Immuno-Photothermal Nanotherapy (SYMPHONY): A Proof of Concept for Localized Bladder Cancer. In: International Journal of Urology. WILEY; 2019. p. 93–93.Link to Item
-
Wang Y, Chang A, Tan WP, Fantony J, Barton G, Wischmeyer P, et al. INCREASING ADIPOSITY IN BLADDER CANCER SURVIVORS: DOES DIET MATTER? In: Journal of Urology. LIPPINCOTT WILLIAMS & WILKINS; 2019. p. E47–E47.Link to Item
-
Barton G, Liu Y, Maccarini P, Palmer G, Etienne W, Tan WP, et al. TOXICITY AND BIODISTRIBUTION OF GOLD NANOPARTICLE-BASED PHOTO-IMMUNO-NANOTHERAPY FOR BLADDER CANCER. In: Journal of Urology. 2019. p. E818–E818.Link to Item
-
Tan WP, Chang A, Barton G, Etienne W, Inman BA. THE EFFECT OF CONDUCTIVE HYPERTHERMIA ON MITOMYCIN C ABSORPTION DURING INTRAVESICAL CHEMOTHERAPY. In: Journal of Urology. 2019. p. E134–E134.Link to Item
-
Barton GJ, Wang J, Chang A, Tan WP, Fantony JJ, Wischmeyer PE, et al. Sarcopenia in bladder cancer patients is an unmodifiable outcomes predictor. In: Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2019. p. 480–480.Full Text
-
Tan WP, Barton GJ, Chang A, Nair S, Inman BA. Sipuleucel-T to modify the B7-H3 immune checkpoint in men with castrate resistant prostate cancer. In: Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2019. p. 273–273.Full Text
-
Liu Y, Maccarini P, Palmer GM, Inman BA, Vo-Dinh T. Abstract 4152: Synergistic gold nanostar-mediated photothermal and immunotherapy for cancer metastasis treatment. In: Tumor Biology. American Association for Cancer Research; 2018.Full Text
-
Chang A, Nair S, George D, Inman B. SIPULEUCEL-T IMMUNOTHERAPY FOR CASTRATE-RESISTANT PROSTATE CANCER MODULATES SOLUBLE B7-H3: A NOVEL MECHANISM OF ACTION. In: Journal of Urology. ELSEVIER SCIENCE INC; 2018. p. E373–E373.Link to Item
-
Freedland S, Aronson W, Howard L, Smith J, Smith M, Stout J, et al. SECONDARY OUTCOMES OF A PROSPECTIVE RANDOMIZED TRIAL OF DIETARY CARBOHYDRATE RESTRICTION FOR MEN INITIATING ANDROGEN DEPRIVATION THERAPY: CARBOHYDRATE AND PROSTATE STUDY I (CAPS1). In: Journal of Urology. ELSEVIER SCIENCE INC; 2018. p. E309–E309.Link to Item
-
Inman B, Vu T, Yu EY, Campogan D, Haynes H, Sheikh NA, et al. REAL-TIME IMAGING DEMONSTRATING T-CELL MEDIATED DESTRUCTION OF PROSTATIC ACID PHOSPHATASE (PAP)-EXPRESSING CELLS IN PATIENTS (PTS) TREATED WITH SIPULEUCEL-T (SIP-T). In: Journal of Urology. ELSEVIER SCIENCE INC; 2018. p. E307–E307.Link to Item
-
Lotan Y, Messing E, Inman B, Daneshmand S, Kassouf W, Canter D, et al. EVALUATION OF THE UROVYSION (TM) TEST FOR PREDICTING RECURRENCE AND PROGRESSION IN PATIENTS RECEIVING BCG FOR HIGH GRADE NON-MUSCLE INVASIVE BLADDER CANCER. In: Journal of Urology. ELSEVIER SCIENCE INC; 2018. p. E101–E101.Link to Item
-
Vo-Dinh T, Inman B, Maccarini P, Palmer G, Liu Y. Synergistic immuno photothermal nanotherapy (SYMPHONY) to treat metastatic cancers and induce anti-cancer vaccine effect. In: Progress in Biomedical Optics and Imaging Proceedings of Spie. 2018.Full Text
-
Brousell SC, Liu Y, Maccarini PF, Palmer GM, Etienne W, Zhao Y, et al. MP98-09 SYNERGISTIC IMMUNO-PHOTOTHERMAL NANOTHERAPY (SYMPHONY): A NOVEL TREATMENT FOR LOCALIZED AND METASTATIC BLADDER CANCER. In: Journal of Urology. Ovid Technologies (Wolters Kluwer Health); 2017.Full Text
-
Brousell SC, Longo TA, Fantony JJ, Etienne W, Needham D, Dewhirst MW, et al. MP65-08 HEAT-TARGETED DRUG DELIVERY USING THE COMBAT BRS DEVICE FOR TREATING BLADDER CANCER. In: Journal of Urology. Ovid Technologies (Wolters Kluwer Health); 2017.Full Text
-
Fantony J, Gopalakrishna A, Longo T, Inman B. MP01-08 NO DIFFERENCE IN PHYSICAL ACTIVITY IN BLADDER CANCER SURVIVORS TREATED WITH TRANSURETHRAL RESECTION OR RADICAL CYSTECTOMY. In: Journal of Urology. Ovid Technologies (Wolters Kluwer Health); 2016.Full Text
-
Freedland S, Aronson W, Howard L, Smith J, Smith M, Stout J, et al. MP04-06 A PROSPECTIVE RANDOMIZED TRIAL OF DIETARY CARBOHYDRATE RESTRICTION FOR MEN INITIATING ANDROGEN DEPRIVATION THERAPY: CARBOHYDRATE AND PROSTATE STUDY I (CAPS1). In: Journal of Urology. Ovid Technologies (Wolters Kluwer Health); 2016.Full Text
-
Gopalakrishna A, Longo T, Fantony J, Inman B. MP01-06 DRAMATIC RACIAL DISPARITIES IN DIETARY MICRONUTRIENT INTAKE AMONG BLADDER CANCER SURVIVORS. In: Journal of Urology. Ovid Technologies (Wolters Kluwer Health); 2016.Full Text
-
Longo T, Gopalakrishna A, Fantony J, Owusu R, Lance R, Foo W-C, et al. MP01-09 CAN A GENE METHYLATION ASSAY IMPROVE THE PERFORMANCE OF CYTOLOGY? In: Journal of Urology. Ovid Technologies (Wolters Kluwer Health); 2016.Full Text
-
Gopalakrishna A, Fantony JJ, Longo TA, Inman BA. Associations between health-related quality of life and physical activity in bladder cancer survivors: A cross-sectional study. In: Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2016. p. 432–432.Full Text
-
Longo TA, Gopalakrishna A, Fantony JJ, Inman BA. Effect of diet on bladder cancer survivors. In: Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2016. p. 437–437.Full Text
-
Longo TA, Gopalakrishna A, Fantony JJ, Inman BA. Your opinion counts: How do you treat atypical/suspicious cytology? In: Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2016. p. 463–463.Full Text
-
Canter D, Boorjian S, Ogan K, Shore N, Bivalacqua T, Bochner B, et al. PD17-06 RANDOMIZED PHASE II TRIAL OF INTRAVESICAL ADENOVIRAL MEDIATED INTERFERON-α GENE THERAPY WITH THE EXCIPIENT SYN3 (RAD-IFNα/SYN3) IN PATIENTS WITH BCG REFRACTORY OR RELAPSING HIGH GRADE (HG) NON MUSCLE INVASIVE BLADDER CANCER (NMIBC). In: Journal of Urology. Ovid Technologies (Wolters Kluwer Health); 2015.Full Text
-
Mendez M, Bassett M, Abern M, Banez L, Ferrandino M, Robertson C, et al. MP14-13 WEIGHING IN ON ACTIVE SURVEILLANCE: IMPACT OF OBESITY ON PATIENT COUNSELING. In: Journal of Urology. Ovid Technologies (Wolters Kluwer Health); 2015.Full Text
-
McGinley K, Etienne W, Moy C, Szabo S, Greshock J, Inman B. MP39-06 WHOLE EXOME SEQUENCING OF THE CANCER GENOME IN PATIENTS WITH VERY HIGH RISK MUSCLE INVASIVE BLADDER CANCER. In: Journal of Urology. Ovid Technologies (Wolters Kluwer Health); 2014.Full Text
-
Abern M, Vujaskovic Z, Dewhirst MW, Lan L, Craciunescu OI, Stauffer P, et al. Phase I clinical trial of external hyperthermia and intravesical mitomycin C to treat BCG-refractory bladder cancer. In: Journal of Clinical Oncology. AMER SOC CLINICAL ONCOLOGY; 2013.Link to Item
-
Glass O, Inman BA, Courneya KS, Mackey JR, Nelson E, Hartman Z, et al. Abstract 1376: Exercise alters breast cancer phenotype through distinct reductions in host-derived proinflammatory growth factor ligands. In: Clinical Research. American Association for Cancer Research; 2013.Full Text
-
Seideman C, Canter D, Kim P, Cordon B, Weizer A, Oliva I, et al. 391 MULTICENTER EVALUATION OF THE ROLE OF UROVYSION FISH ASSAY IN SURVEILLANCE OF PATIENTS WITH BLADDER CANCER: DOES FISH POSITIVITY ANTICIPATE RECURRENCE? In: Journal of Urology. Ovid Technologies (Wolters Kluwer Health); 2013.Full Text
-
Keeney MG, Schoolmeester JK, Swapp RE, Inman BA, Lohse CM, Sebo TJ. Clinical Follow-Up of Patients with Initial ASAP Biopsy Reclassified by a Urologic Pathologist as Benign, ASAP or Cancer: Does "Accurate" Interpretation Have Clinical Relevance? In: Laboratory Investigation. NATURE PUBLISHING GROUP; 2013. p. 224A-224A.Link to Item
-
Keeney MG, Schoolmeester JK, Swapp RE, Inman BA, Lohse CM, Sebo TJ. Clinical Follow-Up of Patients with Initial ASAP Biopsy Reclassified by a Urologic Pathologist as Benign, ASAP or Cancer: Does "Accurate" Interpretation Have Clinical Relevance? In: Modern Pathology. NATURE PUBLISHING GROUP; 2013. p. 224A-224A.Link to Item
-
Keeney MG, Schoolmeester JK, Swapp RE, Lohse CM, Inman BA, Sebo TJ. Histologic Variables and Patient Outcome in Prostate Biopsies with Atypical Small Acinar Proliferation Reclassified as Benign, ASAP or Cancer by Re-Review. In: Laboratory Investigation. NATURE PUBLISHING GROUP; 2013. p. 224A-224A.Link to Item
-
Keeney MG, Schoolmeester JK, Swapp RE, Lohse CM, Inman BA, Sebo TJ. Histologic Variables and Patient Outcome in Prostate Biopsies with Atypical Small Acinar Proliferation Reclassified as Benign, ASAP or Cancer by Re-Review. In: Modern Pathology. NATURE PUBLISHING GROUP; 2013. p. 224A-224A.Link to Item
-
Bassett M, Abern M, Banez LL, Ferrandino M, Robertson CN, Inman BA, et al. African American race to predict for earlier failure of active surveillance: Results from the Duke Prostate Center. In: Journal of Clinical Oncology. AMER SOC CLINICAL ONCOLOGY; 2012.Link to Item
-
Goldsmith Z, Wang A, Lipkin M, Banez L, Iqbal M, Astroza G, et al. 1173 OUTCOMES OF METALLIC RESONANCE® STENTS IN MALIGNANT URETERAL OBSTRUCTION. In: Journal of Urology. Ovid Technologies (Wolters Kluwer Health); 2012.Full Text
-
Banez LL, Davidson AK, Etienne W, Allott EH, Calloway EE, Inman BA. The effect of acute and chronic exposure to acetaldehyde-a mutagenic metabolite of dietary ethanol-on prostate cancer cells: A potential source of race disparity disfavoring black men. In: Journal of Clinical Oncology. AMER SOC CLINICAL ONCOLOGY; 2012.Full Text Link to Item
-
Breau R, Inman B, Nehra A, St. Sauver J, Rangel L, Carlson R, et al. 463 THE ASSOCIATION BETWEEN ANDROGEN DEPRIVATION AND CARDIOVASCULAR EVENTS IN A POPULATION BASED COHORT WITH LONG TERM FOLLOW-UP. In: Journal of Urology. Ovid Technologies (Wolters Kluwer Health); 2011.Full Text
-
Scales C, Chen L, Staheli R, Sexton D, Anderson D, Inman B. 1437 EPIDEMIOLOGY AND VARIATION IN MANAGEMENT OF IATROGENIC BLOODSTREAM INFECTIONS FOLLOWING TRANSRECTAL PROSTATE BIOPSY PROCEDURES. In: Journal of Urology. Ovid Technologies (Wolters Kluwer Health); 2011.Full Text
-
Raymundo MEM, Lipkin ME, Banez LL, Mancini JG, Yong DZ, Zilberman DE, et al. THE ROLE OF ENDOSCOPIC NEPHRON-SPARING SUREGY IN THE MANAGEMENT OF UPPER TRACT UROTHELIAL CARCINOMA. In: Journal of Endourology. MARY ANN LIEBERT INC; 2010. p. A264–5.Link to Item
-
Bradley DA, Morse M, Keler T, Green JA, Davis TA, Inman BA. A randomized phase II study of a novel antigen-presenting cell-targeted hCG-β vaccine (the CDX-1307 regimen) in muscle-invasive bladder cancer. In: Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2010. p. TPS228–TPS228.Full Text
-
Vujaskovic Z, Craciunescu OI, Stauffer P, Carroll M, Lan L, Dewhirst M, et al. Pilot study of external hyperthermia and intravesical mitomycin-C to treat recurrent biadder cancer after failed standard therapy. In: Journal of Clinical Oncology. AMER SOC CLINICAL ONCOLOGY; 2010.Link to Item
-
Siddiqui SA, Boorjian SA, Inman B, Rangel LJ, Bergstralh EJ, Karnes RJ, et al. THE IMPACT OF ADJUVANT THERAPY AFTER RADICAL PROSTATECTOMY FOR PATIENTS WITH PATHOLOGICAL T3b PROSTATE CANCER. In: Journal of Urology. Ovid Technologies (Wolters Kluwer Health); 2008. p. 252–3.Full Text
-
Ashley RA, Routh JC, Siddiqui SA, Inman BA, Sebo TJ, Husmann DA, et al. 920: Pediatric Renal Cell Carcinoma: An Aggressive Tumor with Biologic Features Distinct From Its Adult Counterpart. In: Journal of Urology. Ovid Technologies (Wolters Kluwer Health); 2007. p. 305–305.Full Text
-
Boorjian SA, Siddiqui SA, Inman BA, Slezak JM, Karnes RJ, Blute ML, et al. 1423: The Impact of Gleason Score on the Predictive Value of PSA Doubling Time. In: Journal of Urology. Ovid Technologies (Wolters Kluwer Health); 2007. p. 469–70.Full Text
-
Inman BA, Ashley RA, Routh JC, Wilson T, Mynderse LA, Myers RP, et al. 1948: Saturation Biopsy: Does it Really Detect More Cancer? In: Journal of Urology. Ovid Technologies (Wolters Kluwer Health); 2007. p. 646–7.Full Text
-
Inman BA, Sebo TJ, Frigola X, Dong H, Bergstralh EJ, Fradet Y, et al. 879: PD-L1 (B7-H1) Expression by Urothelial Carcinoma of the Bladder and BCG-Induced Granulomata: Associations with Localized Stage Progression. In: Journal of Urology. Ovid Technologies (Wolters Kluwer Health); 2007. p. 292–292.Full Text
-
Magera JS, Inman BA, Elliott DS. 1496: Does a 5-Day Preoperative Topical Antimicrobial Scrub Reduce Positive Culture Rates in Men Undergoing Artificial Urinary Sphincter Placement? In: Journal of Urology. Ovid Technologies (Wolters Kluwer Health); 2007. p. 493–4.Full Text
-
Routh JC, Kramer SA, Inman BA, Ashley RA, Wolpert JJ, Vandersteen DR, et al. 519: Bladder and Ureteral Anomalies do not Reduce the Efficacy of Dextranomerihyaluronic Acid for Vesicoureteral Reflux. In: Journal of Urology. Ovid Technologies (Wolters Kluwer Health); 2007. p. 173–173.Full Text
-
Routh JC, Vandersteen DR, Ashley RA, Inman BA, Reinberg Y, Wolpert JJ, et al. 518: Routine Contralateral Deflux Injection in Patients with Unilateral Reflux: Increased Cost without Increased Efficacy? In: Journal of Urology. Ovid Technologies (Wolters Kluwer Health); 2007. p. 172–3.Full Text
-
Sengupta S, Blute ML, Bagniewski SM, Inman BA, Leibovich BC, Bergstralh EJ, et al. 1403: “Insignificant” Prostate Cancer Treated by Radical Retropubic Prostatectomy has a Risk of Progression Similar to Low-Risk “Significant” Cancer. In: Journal of Urology. Ovid Technologies (Wolters Kluwer Health); 2007. p. 462–462.Full Text
-
Siddiqui SA, Boorjian SA, Inman BA, Slezak JM, Blute ML. 601: Timing of Androgen Deprivation Therapy and Its Impact on Cancer-Specific Survival after Radical Prostatectomy: A Matched-Cohort Analysis. In: Journal of Urology. Ovid Technologies (Wolters Kluwer Health); 2007. p. 201–201.Full Text
-
Siddiqui SA, Inman BA, Blute ML. 1066: A Thank You to Syphilis for Modern Urography. In: Journal of Urology. Ovid Technologies (Wolters Kluwer Health); 2007. p. 352–352.Full Text
-
Inman BA, Barnes SA, Fradet Y, Lacombe L. 1107: Predictors of Survival for Carcinomas of the Upper Urinary Tract. In: Journal of Urology. Ovid Technologies (Wolters Kluwer Health); 2006. p. 356–356.Full Text
-
Inman BA, Lohse CM, Kwon ED, Cheville JC, Blute ML, Zincke H, et al. 1121: The Relationship between Renal Angiomyolipoma, Renal Cell Carcinoma and Tuberous Sclerosis. In: Journal of Urology. Ovid Technologies (Wolters Kluwer Health); 2006. p. 360–1.Full Text
-
Inman BA, Slezak JM, Kwon ED, Myers RP, Leibovich BC, Blute ML, et al. 646: 25-Year Outcomes of Radical Prostatectomy for the Treatment of All Stages of Non-Metastatic Prostate Cancer. In: Journal of Urology. Ovid Technologies (Wolters Kluwer Health); 2006. p. 208–208.Full Text
-
Inman BA, Lacombe L, Audet J-F, Meyer F, Douville P, Fradet Y. 1668: Insulin-Like Growth Factor Binding Protein 2 is an Independant Predictor of Prostate Cancer Survival. In: Journal of Urology. Ovid Technologies (Wolters Kluwer Health); 2004. p. 441–441.Full Text
-
Inman BA, Lacombe L, Fradet Y. 56: Utility of Routine Urine Cytology in the Followup of Patients with Studer Orthotopic Neobladders. In: Journal of Urology. Ovid Technologies (Wolters Kluwer Health); 2004. p. 15–15.Full Text
-
Inman BA, Lacombe L, Fradet Y. 50: Bacteriologic Profile of Studer Orthotopic Neobladders and the Risk of Urinary Tract Infection. In: Journal of Urology. Ovid Technologies (Wolters Kluwer Health); 2004. p. 14–14.Full Text
-
Inman BA, Tran V-T, Meyer F, Fradet Y, Locombe L. 255: Risk Factors for Bladder Cancer Recurrence Following Urothelial Carcinoma of the Upper Urinary Tract. In: Journal of Urology. Ovid Technologies (Wolters Kluwer Health); 2004. p. 67–67.Full Text
-
Tiguert R, Inman B, Tetu B, Naud A, Gregoire M, Lacombe L, et al. Diagnosis and monitoring of bladder cancer tumors using ImmunoCyt/uCyt plus in routine clinical practice. In: Journal of Urology. LIPPINCOTT WILLIAMS & WILKINS; 2003. p. 225–225.Link to Item
-
-
- Teaching & Mentoring
-
Advising & Mentoring
- I mentor surgeon scientists that are interested in any aspect of genitourinary cancer. Many different experiences are available including clinical trials, epidemiologic and observational research, and translational laboratory research.
Available to mentor:
- Fellow
- Masters
- Resident
- Undergraduate
- Scholarly, Clinical, & Service Activities
-
Service to the Profession
- Associate Editor, European Urology Focus. July 2020 2020
- Member, Research grants and investigator support committee. American Urological Association. May 2017 2017
- Guest editor, International Journal of Hyperthermia. May 2016 2016
- Finance Committee, Southeastern Section of the American Urological Association. December 2014 - June 2019 2014 - 2019
- Chair, Content Review Committee. American Urological Association. May 2014 - May 2018 2014 - 2018
- Society of Urological Oncology Clinical Trials Committee. April 2013 2013
- Toxicological Review of Biphenyl, U.S. Environmental Protection Agency. April 2012 2012
- Consulting editor, European Urology. December 2011 2011
- Bladder and Penile Cancer Guidelines Committee. National Comprehensive Cancer Network . August 2011 - October 2021 2011 - 2021
-
Service to Duke
- Duke KURE K12 Training Grant Advisory Board. August 2013 - April 2016 2013 - 2016
- Division of Urology Research Committee Chair. October 2012 - December 2019 2012 - 2019
- Duke Institutional Review Board. December 2011 - December 2017 2011 - 2017
- Duke Urology family medicine rotation director. October 2009 - October 2012 2009 - 2012
- Division of Urology CME committee. October 2008 - September 2012 2008 - 2012
Some information on this profile has been compiled automatically from Duke databases and external sources. (Our About page explains how this works.) If you see a problem with the information, please write to Scholars@Duke and let us know. We will reply promptly.
